XHC:CA:TSX-iShares Global Healthcare (CAD Hedged) (CAD)

ETF | Sector Equity |

Last Closing

CAD 75.18

Change

+0.21 (+0.28)%

Market Cap

CAD 0.65B

Volume

4.10K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.14 (+0.35%)

CAD 2.88B
TEC:CA TD Global Technology Leaders I..

+0.14 (+0.35%)

CAD 2.88B
ZWU:CA BMO Covered Call Utilities ETF

N/A

CAD 1.94B
ZWU:CA BMO Covered Call Utilities ETF

N/A

CAD 1.94B
XIT:CA iShares S&P/TSX Capped Informa..

+0.49 (+0.85%)

CAD 0.65B
XIT:CA iShares S&P/TSX Capped Informa..

+0.49 (+0.85%)

CAD 0.65B
TXF:CA First Asset Tech Giants Covere..

N/A

CAD 0.65B
TXF:CA First Asset Tech Giants Covere..

N/A

CAD 0.65B
HTA:CA Harvest Tech Achievers Growth ..

+0.03 (+0.16%)

CAD 0.63B
HTA:CA Harvest Tech Achievers Growth ..

+0.03 (+0.16%)

CAD 0.63B

ETFs Containing XHC:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.73% 74% C 55% F
Dividend Return 0.56% 33% F 17% F
Total Return 13.29% 51% F 51% F
Trailing 12 Months  
Capital Gain 15.91% 36% F 45% F
Dividend Return 2.46% 59% D- 43% F
Total Return 18.37% 36% F 45% F
Trailing 5 Years  
Capital Gain 60.06% 57% F 73% C
Dividend Return 7.08% 50% F 24% F
Total Return 67.14% 61% D- 73% C
Average Annual (5 Year Horizon)  
Capital Gain 7.63% N/A N/A 63% D
Dividend Return 8.69% N/A N/A 62% D
Total Return 1.05% N/A N/A 37% F
Risk Return Profile  
Volatility (Standard Deviation) 8.58% N/A N/A 85% B
Risk Adjusted Return 101.23% N/A N/A 97% N/A
Market Capitalization 0.65B 93% A 63% D

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.